Shares of Sorrento Therapeutics Inc (NASDAQ: SRNE) traded 13.5% lower in after-hours trading on Tuesday as a reaction to the company firing its Chief Financial Officer Jiong Shao. What Happened: Sorrento Therapeutics, a biotech drug manufacturer in a filing with the Securities and Exchange Commission on Monday stated that Shao is “terminated in its entirety, effectively immediately.” Further, the company announced it has appointed Najjam Asghar as its new CFO.Asghar has already been performing the role of chief accounting officer for the company since June 2019.Why It Matters: Sorrento also claimed that Shao’s termination is in association with the company’s …read more
Source:: Yahoo Finance
